You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 53 No. 8, August 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  SPECIAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (93)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Advances in the Psychosocial Treatment of Anxiety Disorders

Implications for National Health Care

David H. Barlow, PhD; Cassandra L. Lehman

Arch Gen Psychiatry. 1996;53(8):727-735.


Abstract



Recent developments in the psychosocial treatments for anxiety disorders suggest that we have reached an early plateau. Evidence now exists on the effectiveness of psychosocial treatment approaches for every anxiety disorder when compared with no treatment or credible psychosocial placebos. In many cases these procedures have limited clinical effectiveness and much remains to be learned about the disseminability and clinical utility of these approaches in the context of emerging national health care plans. We are just beginning the first generation of multisite studies examining the potentially synergistic effects of proven psychosocial treatments and proven drug treatments. These studies that have substantial significance for national health care are reviewed and some preliminary results are reported.



Author Affiliations



From the Department of Psychology and The Center for Anxiety and Related Disorders, Boston University, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk Factor Research and Prevention for Anxiety Disorders: Introduction to the Special Series on Risk and Prevention of Anxiety Pathology
Schmidt and Zvolensky
Behav Modif 2007;31:3-7.
ABSTRACT  

The Distal Impact of Two First-Grade Preventive Interventions on Conduct Problems and Disorder in Early Adolescence
Ialongo et al.
Journal of Emotional and Behavioral Disorders 2001;9:146-160.
ABSTRACT  

The Quality of Care for Depressive and Anxiety Disorders in the United States
Young et al.
Arch Gen Psychiatry 2001;58:55-61.
ABSTRACT | FULL TEXT  

Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial
Barlow et al.
JAMA 2000;283:2529-2536.
ABSTRACT | FULL TEXT  

Functional Impairment and Co-occurring Psychiatric Disorders in Medically Hospitalized Men
Booth et al.
Arch Intern Med 1998;158:1551-1559.
ABSTRACT | FULL TEXT  

The Contribution of Psychotherapy and Pharmacotherapy Research to National Mental Health Care: Introduction to the Special Series
This Editorial appears in virtually identical form
Arch Gen Psychiatry 1996;53:670-672.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.